A murine monoclonal antibody against the extracellular part of human claudin-1 (6 F6 mAb) was designed and generated, which was specifically able to pick claudin-1 positive CRC cell lines, and no other cross-reactivity was observed. The gene discussed is CLDN1; the disease is colorectal carcinoma.